Comparison of high-dose proton radiotherapy and brachytherapy in localized prostate cancer: A case-matched analysis

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 1, 2012, Pages

  Coen, John J ^a   Zietman, Anthony L ^a   Rossi, Carl J ^b   Grocela, Joseph A ^a   Efstathiou, Jason A ^a   Yan, Yan ^c   Shipley, William U ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

^c Department of Statistics   (United States)

Author keywords

Brachytherapy; Dose escalation; Prostate cancer; Proton radiation

Indexed keywords

BIOCHEMICAL FAILURE; BRACHYTHERAPY; CASE MATCHING; DOSE ESCALATION; GLEASON SCORES; GRAY EQUIVALENT; HIGH DOSE; LOCALIZED PROSTATE CANCER; LOMA LINDA UNIVERSITY MEDICAL CENTERS; MASSACHUSETTS; PROSTATE BRACHYTHERAPY; PROSTATE CANCERS; PROSTATE SPECIFIC ANTIGEN; PROTON RADIATION; PROTON RADIATIONS; PROTON RADIOTHERAPY; QUALITY-OF-LIFE; RANDOMIZED TRIAL; STRATIFIED ANALYSIS;

ANTIGENS; DISEASES; HOSPITALS; ONCOLOGY; PROTONS;

RADIOTHERAPY;

IODINE 125; PALLADIUM 103; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; GLEASON SCORE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSTATE CANCER; PROTON THERAPY; RADIATION DOSE;

AGE FACTORS; AGED; BRACHYTHERAPY; CALIFORNIA; CASE-CONTROL STUDIES; HUMANS; IODINE RADIOISOTOPES; MALE; MASSACHUSETTS; MIDDLE AGED; NEOPLASM GRADING; PALLADIUM; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTONS; RADIOISOTOPES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; SEMINAL VESICLES; TREATMENT FAILURE;

EID: 83955164302     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.01.039     Document Type: Article

References (31)

1. P.A. Kupelian, L. Potters, and D. Khuntia Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer Int J Radiat Oncol Biol Phys 58 2004 25 33
2. A.V. D'Amico, R. Whittington, and S.B. Malkowicz Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1998 969 974
3. T.N. Eade, E.M. Horwitz, and K. Ruth A comparison of acute and chronic toxicity for men with low-risk prostate cancer treated with intensity-modulated radiation therapy or (125)I permanent implant Int J Radiat Oncol Biol Phys 71 2008 338 345
4. A.L. Zietman, K. Bae, and J.D. Slater Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: Long-term results from Proton Radiation Oncology Group/American College of Radiology 95-09 J Clin Oncol 28 2010 1106 1111
5. M. Roach 3rd, G. Hanks, and H. Thames Jr. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference Int J Radiat Oncol Biol Phys 65 2006 965 974
6. D.A. Kuban, L.B. Levy, and L. Potters Comparison of biochemical failure definitions for permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 65 2006 1487 1493
7. J.W. Denham, M. Kumar, and P.S. Gleeson Recognizing false biochemical failure calls after radiation with or without neo-adjuvant androgen deprivation for prostate cancer Int J Radiat Oncol Biol Phys 74 2009 404 411
8. T. Pickles Prostate-specific antigen (PSA) bounce and other fluctuations: Which biochemical relapse definition is least prone to PSA false calls? An analysis of 2030 men treated for prostate cancer with external beam or brachytherapy with or without adjuvant androgen deprivation therapy Int J Radiat Oncol Biol Phys 64 2006 1355 1359
9. M.J. Zelefsky, J. Moughan, and J. Owen Changing trends in national practice for external beam radiotherapy for clinically localized prostate cancer: 1999 Patterns of Care survey for prostate cancer Int J Radiat Oncol Biol Phys 59 2004 1053 1061
10. P. Kupelian, D. Kuban, and H. Thames Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: The combined experience of nine institutions in patients treated in 1994 and 1995 Int J Radiat Oncol Biol Phys 61 2005 415 419
11. S.T. Peeters, W.D. Heemsbergen, and P.C. Koper Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy J Clin Oncol 24 2006 1990 1996
12. D.A. Kuban, S.L. Tucker, and L. Dong Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer Int J Radiat Oncol Biol Phys 70 2008 67 74
13. P.D. Grimm, J.C. Blasko, and J.E. Sylvester 10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy [see comment] Int J Radiat Oncol Biol Phys 51 2001 31 40
14. G.S. Merrick, W.M. Butler, and K.E. Wallner Monotherapeutic brachytherapy for clinically organ-confined prostate cancer W V Med J 101 2005 168 171
15. M.J. Zelefsky, T. Hollister, and A. Raben Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer Int J Radiat Oncol Biol Phys 47 2000 1261 1266
16. L. Potters, C. Morgenstern, and E. Calugaru 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer J Urol 173 2005 1562 1566
17. R.G. Stock, N.N. Stone, and A. Tabert A dose-response study for I-125 prostate implants Int J Radiat Oncol Biol Phys 41 1998 101 108
18. A.Y. Ho, R.J. Burri, and J.A. Cesaretti Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy Int J Radiat Oncol Biol Phys 75 2009 16 22
19. L. Potters, M. Roach 3rd, and B.J. Davis Postoperative nomogram predicting the 9-year probability of prostate cancer recurrence after permanent prostate brachytherapy using radiation dose as a prognostic variable Int J Radiat Oncol Biol Phys 76 2010 1061 1065
20. M.J. Zelefsky, D.A. Kuban, and L.B. Levy Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation Int J Radiat Oncol Biol Phys 67 2007 327 333
21. T. Pickles, M. Keyes, and W.J. Morris Brachytherapy or conformal external radiotherapy for prostate cancer: A single-institution matched-pair analysis Int J Radiat Oncol Biol Phys 76 2010 43 49
22. F.A. Vicini, L.L. Kestin, and A.A. Martinez The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer Int J Radiat Oncol Biol Phys 45 1999 553 561
23. J.J. Coen, C.S. Chung, and W.U. Shipley Influence of follow-up bias on PSA failure after external beam radiotherapy for localized prostate cancer: Results from a 10-year cohort analysis Int J Radiat Oncol Biol Phys 57 2003 621 628
24. K. Wallner, G. Merrick, and L. True 125I versus 103Pd for low-risk prostate cancer: Preliminary PSA outcomes from a prospective randomized multicenter trial Int J Radiat Oncol Biol Phys 57 2003 1297 1303
25. B. Pickett, J. Kurhanewicz, and J. Pouliot Three-dimensional conformal external beam radiotherapy compared with permanent prostate implantation in low-risk prostate cancer based on endorectal magnetic resonance spectroscopy imaging and prostate-specific antigen level Int J Radiat Oncol Biol Phys 65 2006 65 72
26. R.C. Chen, J.A. Clark, and J.A. Talcott Individualizing quality-of-life outcomes reporting: How localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function J Clin Oncol 27 2009 3916 3922
27. M.G. Sanda, R.L. Dunn, and J. Michalski Quality of life and satisfaction with outcome among prostate-cancer survivors N Engl J Med 358 2008 1250 1261
28. G. Steineck, F. Helgesen, and J. Adolfsson Quality of life after radical prostatectomy or watchful waiting N Engl J Med 347 2002 790 796
29. J.A. Talcott, C. Rossi, and W.U. Shipley Patient-reported long-term outcomes after conventional and high-dose combined proton and photon radiation for early prostate cancer JAMA 303 2010 1046 1053
30. J.A. Efstathiou, A.V. Trofimov, and A.L. Zietman Life, liberty, and the pursuit of protons: An evidence-based review of the role of particle therapy in the treatment of prostate cancer Cancer J 15 2009 312 318
31. A. Konski, W. Speier, and A. Hanlon Is proton beam therapy cost effective in the treatment of adenocarcinoma of the prostate? J Clin Oncol 25 2007 3603 3608